All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Ongoing | 2004-005267-21 | A RANDOMIZED PHASE II PREVENTION TRIAL IN SUBJECTS AT HIGH RISK FOR HORMONE NON RESPONSIVE BREAST CANCER | not-yet-due | |
| Completed, but no date | 2005-001132-72 | A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma. | bad-data | |
| Ongoing | 2005-001503-19 | CLINICAL AND BIOLOGICAL STUDY ON THE ADMINISTRATION OF THALIDOMIDE IN PATIENTS WITH PRIMARY CANCER OF THE LIVER | not-yet-due | |
| Completed, but no date | 2005-004614-32 | Randomized phase II trial of Budesonide Turbuhaler 800 micrograms/twice daily versus placebo in high-risk population with undetermined lung nodules detected at screening low dose CT scan | bad-data | |
| Completed, but no date | 2005-005039-86 | A phase II study of Pegylated Liposomal Doxorubicin PLD as preoperative treatment for elderly patients with locally advanced primary breast cancer. | bad-data | |
| Completed, but no date | 2005-005046-39 | A randomized phase II study to assess the activity and tolerability of two regimens of metronomic oral chemotherapy methotrexate plus cyclophosphamide and cyclophosphamide plus capecitabine combi... | bad-data | |
| Completed, but no date | 2005-005048-19 | A phase II randomised study to investigate the effects of Bevacizumab on cell proliferation and on pCR in patients with locally advanced operable breast cancer | bad-data | |
| Ongoing | 2005-005775-15 | Pilot phase II study of a combined immunotherapy protocol based on oral vaccination and direct intratumoral injection of Salmonella Typhi Ty21a Vivotif in metastatic cutaneous melanoma patients. | not-yet-due | |
| Completed, but no date | 2006-000520-14 | A PHASE II STUDY OF GW572016 LAPATINIBTM ON CELL PROLIFERATION IN HER-2/neu ErbB2 POSITIVE BREAST CANCER BEFORE SURGERY. | bad-data | |
| Ongoing | 2006-002152-16 | Phase II randomized study of intravenous bevacizumab with sequential versus concurrent oral vinorelbine plus capecitabine in patients with locally advanced or recurrent breast cancer with lymphangitic... | not-yet-due | |
| Completed, but no date Terminated | 2006-002168-24 | O6-alkylguanine-DNA-alkyltransferase modulation study Fotemustine plus Temozolomide phase I/II . | bad-data | |
| Ongoing | 2006-002655-33 | Safety evaluation of the i.v. administration of Visipaque in patients with myeloma or monoclonal gammopathy | not-yet-due | |
| Completed, but no date Terminated | 2006-003495-35 | PHASE II TRIAL OF BORTEZOMIB (VELCADE) IN COMBINATION WITH CHLORAMBUCIL IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTROMﾑS MACROGLOBULINEMIA OR SMALL LYMPHOCYTIC LYMPHOMA. A MULTICENTER STUDY. | bad-data | |
| Ongoing | 2006-004856-19 | PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX), CISPLATINUM AND FLUOROURACIL AS CONTINUOUS INFUSION (CCF) IN LOCALLY | not-yet-due | |
| Ongoing | 2006-005004-14 | A phase II study about the use of intensified hybrid chemotherapy regimen ChLVVP/ABVVP in advanced Hodgkin lymphoma patients. | not-yet-due | |
| Ongoing | 2006-005831-44 | A new induction therapy (ThalDoDex) for multiple myeloma. A phase II study. | not-yet-due | |
| Completed, but no date | 2006-006010-15 | PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX), CISPLATINUM | bad-data | |
| Ongoing | 2007-002059-18 | A Phase II study evaluating intermittent letrozole as adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, early stage breast cancer | not-yet-due | |
| Completed, but no date Terminated | 2007-002588-28 | PHASE II STUDY OF METRONOMIC ORAL VINORELBINE IN ADVANCED BREAST | bad-data | |
| Ongoing | 2007-003309-28 | EFFECT OF MECHANICAL BOWEL PREPARATION WITH POLYETHYLENE GLYCOL PLUS BOWEL ENEMA (GLYCERIN 5%) VS BOWEL ENEMA ALONE IN PATIENTS CANDIDATES TO COLORECTAL RESECTION FOR MALIGNANCY. PROSPECTIVE RANDOMIZE... | not-yet-due | |
| Ongoing | 2007-003856-12 | PREvention of atrial fibrillation in patientS undergoing thorAcic surGEry for lung cance | not-yet-due | |
| Ongoing | 2007-006025-27 | A phase II study of metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with bevacizumab and erlotinib (BEXE), plus trastuzumab in HER2/neu positive tumors (BEXET), in advanc... | not-yet-due | |
| Ongoing | 2007-006026-10 | PREOPERATIVE ENDOCRINE TREATMENT WITH LETROZOLE ± TRIPTORELIN IN PATIENTS WITH ER AND PgR POSITIVE LOCALLY ADVANCED BREAST CANCER | not-yet-due | |
| Not reported Terminated | 2007-006306-25 | A phase II study of primary chemotherapy with pegylated liposomal doxorubicin (Caelyx), Cisplatin, and Fluorouracil (CCF) followed by metronomic Capecitabine, Cyclophosphamide and Sorafenib (CCS) in e... | 2009-05-04 | due-trials |
| Ongoing | 2008-000341-64 | EVALUATION OF ACQUIRED OVEREXPRESSION OF HER2/neu ON CIRCULATING TUMOR CELLS IN PATIENTS WITH ADVANCED BREAST CANCER DURING CHEMOTHERAPY, AND ASSESSMENT OF ACTIVITY OF TRASTUZUMAB-BASED THERAPY: A PHA... | not-yet-due | |
| Ongoing | 2008-000688-41 | IMATINIB MESYLATE IN ADVANCED LOW GRADE SOLID TUMORS EXPRESSING IMATINIB MESYLATE TARGETS | not-yet-due | |
| Completed, but no date Terminated | 2008-002958-37 | Differences in dynamic contrast-enhanced (DCE) MRI measurements using Magnevist (Gd-DTPA) and Vas-ovist in patients with untreated squamous cell cervical carcinoma. | bad-data | |
| Ongoing | 2008-004169-25 | Phase II study of Exemestane dose intensification (150 mg daily) in postmenopausal patients with advanced breast cancer progressing under standard dose Exe (25 mg daily) given as adjuvant or palliativ... | not-yet-due | |
| Completed, but no date | 2008-004912-10 | A pre-surgical phase II study on activity of Metformin on breast cancer cells proliferation. | bad-data | |
| Completed, but no date Terminated | 2008-006262-28 | Allogeneic Haematopoietic Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients with Refractory Triple Negative Br... | bad-data | |
| Ongoing | 2008-006383-10 | A phase II randomized study evaluating the role of 8 courses of primary chemotherapy versus 4 courses of primary chemotherapy in combination with endocrine therapy in locally advanced breast canc... | not-yet-due | |
| Ongoing | 2009-009937-14 | Metronomic Capecitabine plus Docetaxel as first line treatment for metastatic breast cancer patients: a phase II trial | not-yet-due | |
| Completed, but no date Terminated | 2009-009938-33 | Temozolomide in the chemo-immuno-therapy of refractory acute leukaemia of adult patients: The TRIAC protocol | bad-data | |
| Ongoing | 2009-010260-41 | Breast cancer prevention with fenretinide in young women at genetic and familial risk. A phase III randomized clinical trial | not-yet-due | |
| Ongoing | 2009-012048-18 | �Fase II study with epirubicin, cisplatin and infusional fluorouracil (ECF) followed by weekly paclitaxel plus metronomic cyclophosphamide � trastuzumab as preoperative treatment of locally advance... | not-yet-due | |
| Ongoing | 2009-012049-46 | Phase III, randomized, double blind trial on Vitamin D supplementation for resected stage II melanoma patients. | not-yet-due | |
| Completed, but no date | 2009-014833-26 | Phase IIB Randomized, Placebo Controlled Trial of Pioglitazone for Oral Premalignant Lesions. An Inter-Consortium Collaborative Study. | bad-data | |
| Ongoing | 2009-016453-17 | Phase II study of preoperative bevacizumab plus weekly paclitaxel, carboplatin and metronomic cyclophosphamide � trastuzumab and endocrine therapy for inflammatory breast cancer | not-yet-due | |
| Ongoing | 2009-018083-94 | Nonmyeloablative Hematopoietic Stem Cell Transplantation for Patients with High-Risk Hematologic Malignancies using Related, HLA-Haploidentical Donors: A Phase II Trial of Combined Immunosuppression w... | not-yet-due | |
| Ongoing | 2010-018519-14 | Rituximab-2cda + Rituximab maintenance in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma | not-yet-due | |
| Ongoing | 2010-020472-34 | 18F-Fluorothymidine Positron Emission Tomography as an early predictor of response to neoadjuvant therapy in patients with locally advanced breast carcinoma | not-yet-due | |
| Ongoing | 2010-020835-38 | “A phase II study of cisplatin plus cyclophospamide for patients with previously treated, advanced, triple receptor negative breast cancer” | not-yet-due | |
| Ongoing | 2010-021815-18 | - Identification of the sentinel node in breast cancer with fluorescence lymphography using indocyanine green dye (ICG): pilot study. | not-yet-due | |
| Ongoing | 2010-022183-12 | Phase II study of metronomic oral Vinorelbine plus Bevacizumab as first line treatment for metastatic breast cancer patients | not-yet-due | |
| Completed, but no date | 2010-022967-37 | Bowel cleansing for colonoscopy: comparison between a same day low-volume preparation and a conventional split one. | bad-data | |
| Ongoing | 2010-024266-21 | A phase II study of metronomic oral chemotherapy with cyclophosphamide plus capecitabine and vinorelbine in metastatic breast cancer patients | not-yet-due | |
| Ongoing | 2010-024603-26 | A phase II study of low-dose vaginal estrogens in pre and postmenopausal breast cancer patients with urogenital atrophy | not-yet-due | |
| Ongoing | 2011-002288-29 | New frontiers in breast imaging: contrast enhanced digital mammography. - Clinical performance of contrast-enhanced spectral mammography (CESM - SenoBright) in pre-surgical evaluation of extent of m... | not-yet-due | |
| Ongoing | 2011-002542-12 | Lymphatic mapping in oropharyngeal neoplasms: comparison between Dynamic Lymphoscintigrafy and Fluorescence Lymphografy using indocyanine green dye (ICG). Validation study. | not-yet-due | |
| Ongoing | 2011-005275-16 | Radio-guided minimally invasive resection of early colon cancer | not-yet-due | |
| Ongoing | 2012-001978-28 | A Phase II study of intermittent letrozole plus transdermal estradiol gel 3 month-therapy as adjuvant endocrine treatment for postmenopausal women with hormone-receptor positive early stage breast c... | not-yet-due | |
| Ongoing | 2012-002248-26 | Prevention of anthracycline-induced cardiotoxicity: a multicentre randomizedtrial comparing two therapeutic strategies. | not-yet-due | |
| Ongoing | 2012-002765-36 | SIB –IMRT using a modulated accelerated fractionation for head and neck cancer patients | not-yet-due | |
| Ongoing | 2012-004489-17 | WAVE: Weekly nab-paclitaxel (Abraxane®) Versus Epirubicin in women with early breast cancer who are elderly or unfit for a 3-weekly polychemotherapy regimen: a Phase II Randomized Trial evaluating Act... | not-yet-due | |
| Ongoing | 2013-003336-72 | A Phase IIb study of topic DAC-0060, a synthetic histone deacetylase inhibitor, plus Tazarotene in patients with cutaneous basal cell carcinoma (BCC) | not-yet-due | |
| Ongoing | 2015-005063-16 | A randomized presurgical study with different schedules of exemestane in postmenopausal women with stage 0-II ER-positive breast cancer | not-yet-due | |
| Ongoing | 2018-002172-40 | Primary Ipilimumab and Nivolumab combo-immunotherapy followed by adjuvant Nivolumab in locally advanced or limited metastatic melanoma. | not-yet-due | |
| Ongoing | 2019-000326-22 | The role of Contrast-Enhanced Spectral Mammography (CESM) in the diagnostic process of breast cancer: can it improve specificity of first-line examinations and therefore reduce the suspicious lesions ... | not-yet-due | |
| Ongoing | 2020-002119-23 | COVitaminD Trial: prevention of complications from COVID-19 in cancer patients under active treatment | not-yet-due |